The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche

Treatment patterns and outcomes in patients with KRAS wild type (WT) metastatic colorectal cancer (mCRC) treated in first line with bevacizumab (B) or cetuximab (C) containing regimens.
 
Arthur C. Houts
Employment - Vector Oncology
Research Funding - Genentech (Inst); Onyx (Inst); Sanofi (Inst)
 
Sarika Ogale
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Nicolas Sommer
No Relationships to Disclose
 
Mark Stephen Walker
Honoraria - Merck
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst); Onyx (Inst); Sanofi (Inst)